Return to Home [X]

Exciting News: Introducing the New Essential Evidence Plus!

We are thrilled to announce that a brand-new version of Essential Evidence Plus is on its way! Mark your calendars for the launch date, September 11th, as we are introducing a modern, mobile-first application that will revolutionize your experience. With this update, accessing our valuable content will be easier and more convenient than ever before.

What to Expect from the New Essential Evidence Plus:

  1. Modern Mobile-First Experience: Our new application has been meticulously designed with a mobile-first approach. No matter what device you're using, whether it's a smartphone, tablet, or desktop, you'll enjoy a seamless and intuitive user experience.
  2. Enhanced Accessibility: We understand the importance of accessing content from anywhere, at any time. The new Essential Evidence Plus will provide you with the flexibility to explore our extensive collection of evidence-based resources on the go, making it easier to stay up to date with the latest medical knowledge and interactive tools.
  3. Improved User Interface: We have revamped our user interface to ensure effortless navigation and a visually appealing experience. Finding the information, you need will be quicker and more intuitive, saving you valuable time and effort.

Essential Evidence Plus will be available to users during this transition. However, please note that ability to create new trial and individual subscriptions will not be available from September 8th to September 11th 7:00 AM EST. During this period, we will be working diligently to transfer our existing system to the upgraded platform, ensuring a seamless transition for all users.

We apologize for any inconvenience caused by this temporary interruption. Rest assured, our team is committed to bringing you a superior user experience, and we appreciate your patience and understanding during this time.

Stay Tuned for the New Essential Evidence Plus!

We are counting down the days until September 11th when the new Essential Evidence Plus will be available for you to explore. Get ready to unlock a wealth of evidence-based resources that empower you in your medical decision-making process.

Thank you for your continued support, and we look forward to delivering an exceptional experience with the all-new Essential Evidence Plus!

Essential Evidence Plus

Browse Databases and Tools

Sort by Show per page
  • Treatment for amphetamine dependence and abuse
    Cochrane Systematic Reviews, 15-Apr-2014
  • Treatment for amphetamine psychosis
    Cochrane Systematic Reviews, 21-Jan-2009
  • Treatment for IgG and IgA paraproteinaemic neuropathy
    Cochrane Systematic Reviews, 24-Mar-2015
  • Treatment for Lambert‐Eaton myasthenic syndrome
    Cochrane Systematic Reviews, 16-Feb-2011
  • Treatment for superficial thrombophlebitis of the leg
    Cochrane Systematic Reviews, 25-Feb-2018
  • Tricyclic and related drugs for nocturnal enuresis in children
    Cochrane Systematic Reviews, 20-Jan-2016
  • Tricyclic drugs for depression in children and adolescents
    Cochrane Systematic Reviews, 18-Jun-2013
  • Trifluoperazine for schizophrenia
    Cochrane Systematic Reviews, 26-Jan-2004
  • Troleandomycin as an oral corticosteroid sparing agent in stable asthma
    Cochrane Systematic Reviews, 23-Oct-2000
  • Unfractionated or low‐molecular weight heparin for induction of remission in ulcerative colitis
    Cochrane Systematic Reviews, 5-Aug-2015
  • Valproate for schizophrenia
    Cochrane Systematic Reviews, 24-Nov-2016
  • Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder
    Cochrane Systematic Reviews, 16-Oct-2013
  • Vancomycin for prophylaxis against sepsis in preterm neonates
    Cochrane Systematic Reviews, 24-Jan-2000
  • Vasoactive drugs for acute stroke
    Cochrane Systematic Reviews, 7-Jul-2010
  • Vasodilators and vasoactive substances for idiopathic sudden sensorineural hearing loss
    Cochrane Systematic Reviews, 7-Oct-2009
  • Vasodilators for primary Raynaud's phenomenon
    Cochrane Systematic Reviews, 17-May-2021
  • Vitamin D and vitamin D analogues for preventing fractures in post‐menopausal women and older men
    Cochrane Systematic Reviews, 14-Apr-2014
  • Vitamin E for Alzheimer's dementia and mild cognitive impairment
    Cochrane Systematic Reviews, 18-Apr-2017
  • Vitamin E for antipsychotic‐induced tardive dyskinesia
    Cochrane Systematic Reviews, 17-Jan-2018
  • Vitamin E for intermittent claudication
    Cochrane Systematic Reviews, 26-Jan-1998

Login or Subscribe


Not Yet a Subscriber?

Doctor with handheld

We offer subscriptions for individuals and institutions

To find out about all the benefits of a year-long subscription to Essential Evidence Plus, click the button below!

Learn More